# A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

> **NCT01325558** · PHASE1 · COMPLETED · sponsor: **Altor BioScience** · enrollment: 30 (estimated)

## Conditions studied

- Locally Advanced Malignant Neoplasm
- Malignant Solid Tumour

## Interventions

- **BIOLOGICAL:** ALT-836 in combination with gemcitabine

## Key facts

- **NCT ID:** NCT01325558
- **Lead sponsor:** Altor BioScience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-08
- **Final completion:** 2015-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325558, "A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01325558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*